penicillamine has been researched along with Thyroid Diseases in 2 studies
Penicillamine: 3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease.
penicillamine : An alpha-amino acid having the structure of valine substituted at the beta position with a sulfanyl group.
Thyroid Diseases: Pathological processes involving the THYROID GLAND.
Excerpt | Relevance | Reference |
---|---|---|
"The aim of our study was to determine the prevalence of thyroid dysfunction and autoimmune abnormalities in rheumatoid arthritis (RA) and to further investigate the possible association between D-penicillamine and autoimmune thyroiditis." | 5.08 | Thyroid function and immune profile in rheumatoid arthritis. A controlled study. ( Andonopoulos, AP; Christofidou, M; Makri, M; Markou, C; Siambi, V; Vagenakis, AG, 1996) |
"None of the patients with morphea had a history of thyroid pathology and the thyroid screenings were within normal limits." | 2.38 | [Scleroderma and thyroid diseases]. ( Claudy, A; Mourier-Clavreul, MC; Rousset, H, 1989) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andonopoulos, AP | 1 |
Siambi, V | 1 |
Makri, M | 1 |
Christofidou, M | 1 |
Markou, C | 1 |
Vagenakis, AG | 1 |
Mourier-Clavreul, MC | 1 |
Rousset, H | 1 |
Claudy, A | 1 |
1 review available for penicillamine and Thyroid Diseases
Article | Year |
---|---|
[Scleroderma and thyroid diseases].
Topics: Aged; Confidence Intervals; Female; Humans; Incidence; Male; Middle Aged; Penicillamine; Prospective | 1989 |
1 trial available for penicillamine and Thyroid Diseases
Article | Year |
---|---|
Thyroid function and immune profile in rheumatoid arthritis. A controlled study.
Topics: Adult; Aged; Arthritis, Rheumatoid; Female; Humans; Male; Middle Aged; Monitoring, Immunologic; Oste | 1996 |